ESR1 and endometriosis: In a preclinical model of endometriosis, targeting ERs, chloroindazole (CLI) for ERα and oxabicycloheptene sulfonate (OBHS) for ERβ, effectively suppresses endometriosis progression by inhibiting ER-dependent inflammatory activity (40).